An Industry Perspective

An Industry Perspective:  Impacts of FDA Oversight
Monday, December 9 - 2:30 - 3:30 PM

Session Overview

This session will discuss the impacts of FDA regulation.  Attendees will receive insight on product development and associated steps to comply with regulatory oversight. Topics include new business models arising as a result of regulation and real world case studies to highlight key takeaways.

Speakers

Senior Director, Government Affairs
Qualcomm Incorporated
 
Vice President Government and Regulatory Affairs
athenahealth, Inc.
 
CEO
The Tenzing Group
 
 
EBG Partner
Epstein Becker Green